Geode Capital Management, LLC Pro Phase Labs, Inc. Transaction History
Geode Capital Management, LLC
- $1.52 Trillion
- Q3 2025
A detailed history of Geode Capital Management, LLC transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 302,929 shares of PRPH stock, worth $90,878. This represents 0.0% of its overall portfolio holdings.
Number of Shares
302,929
Previous 259,063
16.93%
Holding current value
$90,878
Previous $101,000
31.68%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding PRPH
# of Institutions
30Shares Held
2.98MCall Options Held
13.7KPut Options Held
0-
Sykon Capital LLC Harrison, NY645KShares$193,4380.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA532KShares$159,5750.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA398KShares$119,3740.0% of portfolio
-
Accretive Wealth Partners, LLC Parsippany, NJ250KShares$75,0000.04% of portfolio
-
High Tower Advisors, LLC Chicago, IL237KShares$71,2010.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $4.81M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...